Astec LifeSciences Limited — Board Meeting, 29-10-2025: Outcome of Board Meeting

Astec LifeSciences has announced a board meeting. The Board approved the consolidated financial results for the quarter and half-year ended September 30, 2025. The company reported a Q2 loss of ₹24.42 Cr on revenue of ₹73.72 Cr. For H1, loss was ₹57.44 Cr on ₹164.80 Cr revenue. A rights issue of 26.70 lakh shares at ₹890 was allotted.